Enveric Biosciences Inc (ENVB) 0.2126 0 (-0.79%)

0.2126 0 (-0.79%)

US29405E1091 - Common Stock - After market: 0.213 +0 (+0.19%)

Analysts have set a mean price target of 0.66. This target is 211.85% above the current price.

ENVB was analyzed by 8 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about ENVB.

In the previous month the buy percentage consensus was at a similar level.

ENVB was analyzed by 8 analysts. More opinions would make the average more meaningful.

Price

Low

Median

Mean

High

0.21

0.20

0.51

0.66

1.31

-4.99%

139.89%

211.85%

517.36%

Date	Firm	Action	Rating
2022-06-01	Alliance Global Partners	Initiate	Buy
2022-03-08	Aegis Capital	Downgrade	Buy -> Hold
2021-07-08	Aegis Capital	Initiate	Buy
2021-06-28	Maxim Group	Initiate	Buy

Find the competitors with the best analyst ratings on the USA